Caution indeed...” The next set of great news will be very robust and very positive news to go with "TIH" footing bill, which will also maximize any potential exclusive licensing partnership or buyout solicitation from pharma, if any is in the works.”
There’s no way you can know this. Don’t forget IMHO!